Infusion Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (2013 – 2019) An Infusion system is a device and any associated disposable used to deliver fluids, medication or nutrients in to the patient’s circulatory system. The most common route of administration of such products in patients is intravenous and is followed by subcutaneous, epidural or enteral route. Infusion systems are categorized into in five market segments namely, syringe pumps, infusion disposable sets, implantable infusion pumps, volumetric pumps and ambulatory infusion pumps.
Browse full report at: http://www.transparencymarketresearch.com/infusion-systemsmarket.html
Infusion systems are basically designed to administer fluids which are otherwise impractically expensive or unreliable if done manually by nursing staff. The selection of infusion pump depends on criteria such as the required volume for infusion, long and short term accuracy and the speed of infusion.
The major key factors contributing to the growth of this market is increasing demand for multifunctional infusion systems, advancement in infusion technologies, development in the reimbursement scenario and also increase in aging population and associated high prevalence of chronic pain.
The major contribution for the global infusion systems market comes from North America followed by Europe. Their contribution is attributed to significant chronic pain in people and better reimbursement policies. The North America and Europe regions currently occupy more than half of the global market share for infusion pumps. The next big opportunity for the leading infusion systems manufacturers remains with the emerging economies of China, India, Brazil, Russia and South Africa, due to significantly large number of under-served patients.
The global infusion systems market is highly fragmented in nature with prime market players enjoying approximately similar market shares. The major market players are Baxter International, Inc., CareFusion Corp., Fresenius Kabi AG, Hospira, Inc., ICU Medical, Inc., Medtronic, Inc., JMS Co. Ltd., Nipro Corp., and Terumo Corporation.